First Page | Document Content | |
---|---|---|
Date: 2012-12-17 13:41:33Anti-diabetic medication Leukotriene antagonist Non-steroidal anti-inflammatory drug Muscle relaxant Antibacterial Laxative Anticholinergic Antiestrogen Antiarrhythmic agent Medicine Analgesic Pain | Copy of proposed-ehb-benchmark-plan-michigan1.xlsxAdd to Reading ListSource URL: michigan.govDownload Document from Source WebsiteFile Size: 89,17 KBShare Document on Facebook |
Award ID: DP150096 Project Title: ESR1 Coregulator binding site inhibitors (ECBIs) as novel therapeutics to target hormone therapy resistant metastatic breast cancer Award Mechanism:DocID: 1aiKa - View Document | |
References for Substances Tested in the In Vitro ER Binding Assays: Appx D2 - ICCVAM ER Binding BRD (NIH Publication No[removed])DocID: RQPw - View Document | |
ACOG COMMITTEE OPINION Number 412 • August 2008 Aromatase Inhibitors in Gynecologic Practice Committee onDocID: PTgx - View Document | |
Shift work and adverse health effects: possible biological mechanismsDocID: G8Xf - View Document | |
Endocrine Disruptor Screening and Testing Advisory Committee Final Report - Appendix JDocID: A3xU - View Document |